Table of Contents
Review
| ABC transporters and the hallmarks of cancer: roles in cancer aggressiveness beyond multidrug resistance | |
| Wanjiru Muriithi, Lucy Wanjiku Macharia, Carlos Pilotto Heming, et al. | 253-269 |
| Four and a half LIM domains protein 1 can be as a double-edged sword in cancer progression | |
| Xiaofan Wei, Hongquan Zhang | 270-281 |
| Role of the mechanical microenvironment in cancer development and progression | |
| Qiuping Liu, Qing Luo, Yang Ju, et al. | 282-292 |
| Triple negative breast cancer: special histological types and emerging therapeutic methods | |
| Lu Cao, Yun Niu | 293-306 |
| Magnetic resonance imaging-guided and targeted theranostics of colorectal cancer | |
| Yanan Li, Jingqi Xin, Yongbing Sun, et al. | 307-327 |
Original Article
| CDK11 negatively regulates Wnt/β-catenin signaling in the endosomal compartment by affecting microtubule stability | |
| Danmin Ou, Lin Chen, Jiang He, et al. | 328-342 |
| Heat shock protein 47 promotes tumor survival and therapy resistance by modulating AKT signaling via PHLPP1 in colorectal cancer | |
| Yijye Chern, Peter Zhang, Hyelim Ju, et al. | 343-356 |
| CUL4 E3 ligase regulates the proliferation and apoptosis of lung squamous cell carcinoma and small cell lung carcinoma | |
| Ting Li, Si Wu, Lei Jia, et al. | 357-370 |
| KIF18B promotes tumor progression in osteosarcoma by activating β-catenin | |
| Tian Gao, Ling Yu, Zhiwei Fang, et al. | 371-386 |
| DYRK1A suppression restrains Mcl-1 expression and sensitizes NSCLC cells to Bcl-2 inhibitors | |
| Yangling Li, Dongmei Zhou, Shuang Xu, et al. | 387-400 |
| Time serial transcriptome reveals Cyp2c29 as a key gene in hepatocellular carcinoma development | |
| Qi Wang, Qin Tang, Lijun Zhao, et al. | 401-417 |
| Bevacizumab promotes active biological behaviors of human umbilical vein endothelial cells by activating TGFβ1 pathways via off-VEGF signaling | |
| Xiaoling Zhang, Yan Zhang, Yanan Jia, et al. | 418-432 |
| Boosting of the enhanced permeability and retention effect with nanocapsules improves the therapeutic effects of cetuximab | |
| Chao Yang, Yanli Tan, Hongzhao Qi, et al. | 433-443 |
| Clinical-pathological and molecular characterization of long-term survivors with advanced non-small cell lung cancer | |
| Juan Moreno-Rubio, Santiago Ponce, Rosa Álvarez, et al. | 444-457 |
| Identification of novel Lynch syndrome mutations in Chinese patients with endometriod endometrial cancer | |
| Caixia Ren, Yan Liu, Yuxiang Wang, et al. | 458-467 |
| Value of metabolic parameters in distinguishing primary mediastinal lymphomas from thymic epithelial tumors | |
| Lei Zhu, Xiaofeng Li,, Jian Wang, et al | 468-477 |
| Cholecystectomy is associated with higher risk of recurrence after microwave ablation of hepatocellular carcinoma: a propensity score matching analysis | |
| Hongcai Yang, Yi Yang, Jianping Dou, et al. | 478-491 |
| Validation of the eighth edition of the AJCC staging system for patients with pancreatic adenocarcinoma initially receiving chemoradiotherapy and proposal of modifications | |
| Xiaofei Zhu, Di Chen, Yangsen Cao, et al. | 492-500 |
| Clinical study of apatinib in the treatment of stage IV osteogenic sarcoma after failure of chemotherapy | |
| Zhichao Liao, Ting Li, Chao Zhang, et al | 501-512 |
Erratum
| Erratum to Prevalence and clinical significance of pathogenic germline BRCA1/2 mutations in Chinese non-small cell lung cancer patients | |
| Xingsheng Hu, Dongyong Yang, Yalun Li, et al. | 513 |
OUR FRIENDS
